Key terms
About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VRTX news
Mar 15
11:15am ET
William Blair biotech analysts to hold an analyst/industry conference call
Mar 15
4:55am ET
William Blair biotech analysts to hold an analyst/industry conference call
Mar 14
12:50pm ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 14
11:41am ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 13
5:50am ET
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Medtronic (MDT) and Caribou Biosciences (CRBU)
Mar 10
5:31pm ET
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
Mar 06
2:19pm ET
William Blair biotech analysts to hold an analyst/industry conference call
Mar 06
7:40am ET
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and IO Biotech (IOBT)
Mar 01
9:50am ET
Vertex Pharmaceuticals participates in a conference call with JPMorgan
Mar 01
5:13am ET
Vertex Pharmaceuticals downgraded to Buy from Conviction Buy at Goldman Sachs
Mar 01
4:55am ET
Vertex Pharmaceuticals participates in a conference call with JPMorgan
Feb 29
5:03pm ET
Vertex Pharmaceuticals participates in a conference call with JPMorgan
Feb 26
8:50pm ET
Analysts Offer Insights on Healthcare Companies: Morphic Holding (MORF) and Vertex Pharmaceuticals (VRTX)
Feb 23
4:13pm ET
Vertex Pharmaceuticals CSO Altshuler sells 3,002 common shares
Feb 23
7:20am ET
Vertex Pharmaceuticals reports CHMP opinion for label extension of Kalydeco
Feb 21
6:26pm ET
Crispr Therapeutics price target raised to $112 from $110 at Chardan
Feb 21
3:20am ET
Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)
Feb 17
1:02am ET
A New Cause for Concern: Vertex Pharmaceuticals Inc. Adds a New Regulation Risk
Feb 14
7:34pm ET
Vertex Pharmaceuticals initiated with an Outperform at Wolfe Research
Feb 14
4:16pm ET
Vertex Pharmaceuticals initiated with an Outperform at Wolfe Research
Feb 13
5:01pm ET
Vertex Pharmaceuticals COO Arbuckle sells over $1.8M in shares
Feb 12
9:22am ET
Vertex Pharmaceuticals price target raised to $465 from $420 at Argus
Feb 08
8:58am ET
Crispr Therapeutics price target lowered to $120 from $160 at Truist
Feb 08
1:00am ET
Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Vertex Pharmaceuticals (VRTX)
Feb 07
10:50am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and EyePoint Pharmaceuticals (EYPT)
Feb 07
8:43am ET
Vertex Pharmaceuticals price target lowered to $371 from $378 at Canaccord
Feb 07
8:38am ET
Recommendation to Sell: Vertex Pharmaceuticals’ Lack of Market Expansion and Competitive Edge
Feb 07
8:26am ET
Buy Rating Affirmed for Vertex Pharmaceuticals on Strong Clinical and Financial Performance
Feb 06
11:15pm ET
Vertex Pharmaceuticals (VRTX) Gets a Buy from Wells Fargo
Feb 06
10:32am ET
Vertex Pharmaceuticals price target raised to $472 from $446 at Barclays
Feb 06
9:55am ET
Tesla downgraded, UPS upgraded: Wall Street’s top analyst calls
Mar 17
9:50am ET
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
Mar 17
9:00am ET
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
Mar 17
8:54am ET
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
Mar 09
5:52am ET
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
Mar 05
9:30am ET
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market
No recent press releases are available for VRTX
VRTX Financials
Key terms
Ad Feedback
VRTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VRTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range